Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
CGD NOTES
March 28, 2024
Over the past two decades, China has become a distinctive and increasingly important donor of development assistance for health (DAH). However, little is known about what factors influence China’s priority-setting for DAH. In this study, we provide an updated analysis of trends in the priorities of ...
Blog Post
March 26, 2024
When we launched Pandemic Proof, many countries were still in the throes of the health and economic shocks of COVID-19. Lessons learned from the pandemic were still fresh. And the visibility and urgency of the pandemic catalyzed some important policy action, including the establishment of innovative...
Blog Post
March 20, 2024
In global development and global health circles, the euphemism “graduation” refers to the “transition” to “sustainability,” another euphemism for the reduction in, and ultimately ending of, support from a donor to a recipient country. But what happens to countries after they graduate? In this piece ...
Blog Post
March 19, 2024
oughly, six percent of health allocations are estimated to be siphoned away through corruption. Health systems are particularly vulnerable to corruption because of the complex nature of the provision of health care, information asymmetries and financial fragmentation. To advance progress toward UHC,...
Blog Post
March 18, 2024
Against the odds, a plucky little IMF engine—the Resilience and Sustainability Trust, or RST—has won plaudits for its efforts to support countries formulating policies to tackle climate change. It has taken up the challenge with only $30 billion as firepower, against the trillions needed from all ...
POLICY PAPERS
March 18, 2024
The IMF’s Resilience and Sustainability Trust (RST) has been operational for over a year, with the first seventeen countries receiving commitments of financial support. But if lending from the RST is to achieve its objectives, the IMF should make it fitter for purpose by taking a radically different...
Blog Post
March 18, 2024
Today, Dr. Sania Nishtar assumes her role as Gavi's new CEO. A lot has changed—both within Gavi and in the external environment—since the process began to replace Dr. Seth Berkley, who stepped down last year. Dr. Nishtar’s appointment comes at a critical time for Gavi. As CEO, Dr. Nishtar will play ...
CGD NOTES
March 15, 2024
The November guidance on RSF seems to have addressed some of the shortcomings observed in the initial RSF programs. However, as we highlight in this note, other deficiencies remain unresolved and require attention from the IMF’s Executive Board during the upcoming RSF review.
Blog Post
March 13, 2024
When world leaders gather in September for this year’s UN General Assembly, antimicrobial resistance (AMR) will be on the agenda. For people like me who care passionately about this issue, this is a welcome opportunity to address a global problem with a global solution. Ahead of September, we need t...
Blog Post
March 08, 2024
For nearly 25 years, innovation has been core to Gavi’s success in accelerating vaccine introductions in lower-income countries. Building on this track record, Gavi has a high-impact opportunity to sharpen its focus on scaling innovations for systems improvement in its next five-year strategic perio...